Topics

  • HOME
  • TOPICS
  • Topics
Erratum
1981
Erratum to ‘Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction’ [Clin Mol Hepatol 2024;30:539-560]
Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
Clin Mol Hepatol. 2024;30(4):1060-1065.   Published online July 24, 2024
View: 656   Download: 20
Snapshot
1901
Examining the therapeutic landscape of beta-blockers in portal hypertension
Anna Brujats, Càndid Villanueva
Clin Mol Hepatol. 2024;30(4):1055-1059.   Published online March 6, 2024
View: 5444   Download: 49
Reply to Correspondence
Reply to correspondence on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
Cho-Rong Lee, Sung-Gyoo Park
Clin Mol Hepatol. 2024;30(4):1053-1054.   Published online July 17, 2024
View: 927   Download: 30
Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”
Seren M. Gedallovich, Paul Y. Kwo
Clin Mol Hepatol. 2024;30(4):1050-1052.   Published online July 12, 2024
View: 583   Download: 19
Reply to correspondence on “Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis”
Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
Clin Mol Hepatol. 2024;30(4):1042-1043.   Published online August 27, 2024
View: 390   Download: 19  Crossref: 1
Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
Clin Mol Hepatol. 2024;30(4):1037-1038.   Published online May 2, 2024
View: 906   Download: 47
Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
Eileen Laurel Yoon, Dae Won Jun
Clin Mol Hepatol. 2024;30(4):1033-1034.   Published online May 20, 2024
View: 700   Download: 17
Reply to correspondence on “Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide”
Pin-Nan Cheng, Ming-Lung Yu
Clin Mol Hepatol. 2024;30(4):1031-1032.   Published online April 11, 2024
View: 944   Download: 35
Correspondence
Correspondence on editorial regarding “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
Mehrangiz Dezhbord, Kyun-Hwan Kim
Clin Mol Hepatol. 2024;30(4):1028-1030.   Published online July 9, 2024
View: 949   Download: 69
Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”
Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu
Clin Mol Hepatol. 2024;30(4):1026-1027.   Published online July 8, 2024
View: 549   Download: 35
Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
Clin Mol Hepatol. 2024;30(4):1016-1018.   Published online May 20, 2024
View: 778   Download: 26
Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
Clin Mol Hepatol. 2024;30(4):1005-1008.   Published online May 30, 2024
View: 892   Download: 38
Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
Jiaorong Qu, Le Wang, Xiaojiaoyang Li
Clin Mol Hepatol. 2024;30(4):1002-1004.   Published online May 17, 2024
View: 811   Download: 39
Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”
Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
Clin Mol Hepatol. 2024;30(4):997-999.   Published online July 29, 2024
View: 434   Download: 21
Correspondence to editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”
Haeryoung Kim, Dong Ho Lee, Yoon Jung Hwang
Clin Mol Hepatol. 2024;30(4):992-993.   Published online August 5, 2024
View: 454   Download: 23
Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”
Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
Clin Mol Hepatol. 2024;30(4):987-988.   Published online April 19, 2024
View: 872   Download: 27
Letter to the Editor
Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
Clin Mol Hepatol. 2024;30(4):982-986.   Published online August 27, 2024
View: 508   Download: 35

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 578
TOTAL : 2149458
Close layer